Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LB-001 by Alexion Pharmaceuticals for Methylmalonic Acidemia: Likelihood of Approval
LB-001 is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Methylmalonic Acidemia. According to GlobalData, Phase...